Celltrion’s New Launch of Medication in the US Image Credits: Chosunbiz Announcement Celltrion USA confirmed that OSENVELT (denosumab-bmwo) and STOBOCLO (denosumab-bmwo), references to XGEVA and PROLIA, are available in the US. Access to these medications will improve and enhance patient ...
AI and Genetics: A New Hope for Pharma Companies Image Credits: Allerin Current Situation The pharmaceutical industry is facing difficulties in gaining the public's trust. The drug reactions often cause adverse effects to health and are not suitable for every individual. The advancement and dev...
Nasal COVID-19 Vaccine Demonstrates Positive Results in Phase 1 Clinical Trial Image Credits: NBC News Findings During the extreme stage of the COVID-19 pandemic, scientists noted that the complications of this infection started to increase severely with the SARS-CoV-2 virus entering the nasal ...
Onco-Innovations and Nucro-techniques Partnership to Elevate Human Trials Image Credits: WIVB Announcement Onco-Innovations Limited has signed an agreement with Nucro-technics Inc. on 3rd July 2025. Through this agreement, Nucro-Technics will organize a vast range of preclinical studies contrib...
Drug Development and Real-world Clinical Needs Establish a New Era in Oncology Image Credits: MEDSIR Concern The United States, till now, has completed 321.4% of phase 2/3 clinical trials. The percentage is less than compared of other regions' clinical trials. The patient recruitment and protoc...
Fresenius Medical Care and CCINSHAE's Strategic Collaboration to Expand Innovative Therapy Image Credits: Fresenius Medical Care Announcement Fresenius Medical Care, a global provider of products and services for patients suffering from renal diseases, will expand high-volume hemodiafiltration ...
Innocare’s Received Approval for a Clinical Trial in China Image Credits: BioWorld Announcement Innocare Pharma, a global biopharmaceutical company known for its advanced treatment for autoimmune diseases and cancer, received approval of an IND Investigational New Drug by the CDE Center f...
Brii Biosciences Signed a Licensing Agreement with Joincare Group Image Credits: Vietnam Investment Review Announcement Brii Biosciences, a global biotechnology company known for its excellent therapies for various diseases, has signed a technology transfer and license agreement with Joincare P...
Monte Rosa’s Solution in the Research Article Image Credits: Monte Rosa Therapeutics Inc. Publication Monte Rosa Therapeutics Inc., a global biotechnology company that has discovered molecular glue degrader (MGD) based medicines, introduced discoveries via a research article, featured on ...
Japan’s 3D Bioprinted Human Tissu e Market is Seeking Growth by 2025-2032 Current Status Japan’s 3D Bioprinted Human Tissue Market is concentrating on opportunities and growth in the coming years. The mid-year is focusing on innovation, development, and new engagement in this market t...
